Mdm2 and mdmX prevent ASPP1 and ASPP2 from stimulating p53 without targeting p53 for degradation

Oncogene

Volumn 24, Issue 23, 2005, Pages 3836-3841

  Bergamaschi, Daniele ^a   Samuels, Yardena ^a   Zhong, Shan ^a   Lu, Xin ^a  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

Author keywords

Apoptosis; ASPP; Mdm2; MdmX; P53; Transactivation

Indexed keywords

BINDING PROTEIN; PROTEIN ASPP1; PROTEIN ASPP2; PROTEIN MDM2; PROTEIN MDMX; PROTEIN P53; UNCLASSIFIED DRUG; ASPP1 PROTEIN, HUMAN; CARRIER PROTEIN; DNA; MDM2 PROTEIN, HUMAN; MDM4 PROTEIN, HUMAN; NUCLEAR PROTEIN; ONCOPROTEIN; TP53BP2 PROTEIN, HUMAN;

APOPTOSIS; ARTICLE; DNA BINDING; DRUG INHIBITION; GENE TARGETING; MUTANT; PRIORITY JOURNAL; PROTEIN DEGRADATION; TRANSACTIVATION; DRUG ANTAGONISM; HUMAN; METABOLISM; PHYSIOLOGY;

APOPTOSIS; CARRIER PROTEINS; DNA; HUMANS; NUCLEAR PROTEINS; PROTO-ONCOGENE PROTEINS; PROTO-ONCOGENE PROTEINS C-MDM2; TRANS-ACTIVATION (GENETICS); TUMOR SUPPRESSOR PROTEIN P53;

EID: 19844376859     PISSN: 09509232     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.onc.1208535     Document Type: Article

References (26)

1. Avantaggiati ML, Ogryzko V, Gardner K, Giordano A, Levine AS and Kelly K. (1997). Cell, 89, 1175-1184.
2. Bergamaschi D, Samuel Y, O'Neil NJ, Trigiante G, Crook T, Hsieh KJ, O'Connor DJ, Zhong S, Campargue I, Tomlinson ML, Kuwabara PE and Lu X. (2003). Nat. Genet., 33, 162-167.
3. Bottger V, Bottger A, Garcia-Echeverria C, Ramos YF, van der Eb A, Jochemsen AG and Lane DP. (1999). Oncogene, 18, 189-199.
4. Caelles C, Helmberg A and Karin M. (1994). Nature, 370, 220-223.
5. Chen J, Marechal V and Levine AJ. (1993). Mol. Cell. Biol., 13, 4107-4114.
6. Chipuk JE, Kuwana T, Bouchier-Hayes L, Droin NM, Newmeyer DD, Schuler M and Green DR. (2004). Science, 303, 1010-1014.
7. Cordon-Cardo C, Latres E, Drobnjak M, Oliva MR, Pollack D, Woodruff JM, Marechal V, Chen J, Brennan MF and Levine AJ. (1994). Cancer Res., 54, 794-799.
8. Danovi D, Meulmeester E, Pasini D, Migliorini D, Capra M, Frenk R, de Graaf P, Francoz S, Gasparini P, Gobbi A, Helin K, Pelicci PG, Jochemsen AG and Marine JC. (2004). Mol. Cell. Biol., 24, 5835-5843.
9. de Oca Luna RM, Wagner DS and Lozano G. (1995). Nature, 378, 203-206.
10. Haupt Y, Maya R, Kazaz A and Oren M. (1997). Nature, 387, 296-299.
11. Jackson MW and Berberich SJ. (2000). Mol. Cell. Biol., 20, 1001-1007.
12. Jones SN, Roe AE, Donehower LA and Bradley A. (1995). Nature, 378, 206-208.
13. Kubbutat MH, Jones SN and Vousden KH. (1997). Nature, 387, 299-303.
14. Lill NL, Grossman SR, Ginsberg D, DeCaprio J and Livingston DM. (1997). Nature, 387, 823-826.
15. Lin J, Chen J, Elenbaas B and Levine AJ. (1994). Genes Dev., 8, 1235-1246.
16. Mihara M, Erster S, Zaika A, Petrenko O, Chittenden T, Pancoska P and Moll UM. (2003). Mol. Cell, 11, 577-590.
17. Moll UM and Zaika A. (2001). FEBS Lett., 493, 65-69.
18. Momand J, Zambetti GP, Oslon DC, George D and Levine AJ. (1992). Cell, 69, 1237-1245.
19. Oliner JD, Pietenpol JA, Thiagalingan S, Gyruis J, Kinzler KW and Vogelstein B. (1993). Nature, 362, 857-860.
20. Parant J, Chavez-Reyes A, Little NA, Yan W, Reinke V, Jochemsen AG and Lozano G. (2001). Nat. Genet., 29, 92-95.
21. Ramos YF, Stad R, Attema J, Peltenburg LT, van der Eb AJ and Jochemsen AG. (2001). Cancer Res., 61, 1839-1842.
22. Samuels-Lev Y, O'Connor DJ, Bergamaschi D, Trigiante G, Hsieh JK, Zhong S, Campargue I, Naumovski L, Crook T and Lu X. (2001). Mol. Cell, 8, 781-794.
23. Slee EA, O'Connor DJ and Lu X. (2004). Oncogene, 23, 2809-2818.
24. Stad R, Little NA, Xirodimas DP, Frenk R, van der Eb AJ, Lane DP, Saville MK and Jochemsen AG. (2001). EMBO Rep., 2, 1029-1034.
25. Tang HJ, Qian D, Sondak VK, Stachura S and Lin J. (2004). Br. J. Cancer, 90, 1285-1292.
26. Vousden KH and Lu X. (2002). Nat. Rev. Cancer, 2, 594-604.